Results 21 to 30 of about 12,753 (177)
Introduction: There was limited research on the epidemiology of hyperphosphatemia in early-stage chronic kidney disease (CKD) patients. We aimed to explore the clinical characteristics and prognostic value of hyperphosphatemia in patients with CKD stages
Chao Xie +8 more
doaj +1 more source
Aging impairs vascular function, but the mechanisms involved are unknown. The aim of this study was to analyze whether aging-related hyperphosphatemia is implied in this effect by elucidating the role of oxidative stress.
Ana Asenjo-Bueno +8 more
doaj +1 more source
Recombinant human parathyroid hormone in the therapy of hypoparathyroidism [PDF]
Hypoparathyroidism is an endocrine disease that results from deficiency or complete absence of parathyroid hormone (PTH), a biologically active 84-amino acid polypeptide.
A K Eremkina +3 more
doaj +1 more source
Hyperphosphataemia can originate from tissue ischaemia and damage and may be associated with injury severity in polytrauma patients. In this retrospective, single-centre study, 166 polytrauma patients (injury severity score (ISS) ≥ 16) primarily ...
Christopher Rugg +7 more
doaj +1 more source
Objective To study the efficacy of DZ1462, a novel sodium-phosphate transporter inhibitor, on rat hyperphosphatemia models established by 5/6 nephrectomy.Methods Totally 156 rats were randomly selected into four groups.
LU Xiao +3 more
doaj +1 more source
The Effect of Magnesium Oxide on Hyperphosphatemia in Female Hemodialysis Patients [PDF]
Background: Hyperphosphatemia is a common problem in hemodialysis patients for which various binders are used to control this problem. Objectives: This study aims to assess the effect of magnesium oxide on controlling serum phosphorus levels and evaluate
Maryam Pakfetrat +5 more
doaj +1 more source
Pseudohyperphosphatemia in Multiple Myeloma: A Systematic Review of Case Reports and Case Series
Pseudohyperphosphatemia (PHP) is a clinically significant laboratory artifact in patients with multiple myeloma (MM). It is often caused by paraprotein interference with phosphate assays. This systematic review summarizes reported cases, underlying mechanisms, and diagnostic approaches to distinguish spurious from true hyperphosphatemia.
Mahsa Dabir +3 more
wiley +1 more source
Cardiovascular problems in dialysis patients - focus on correcting hyperphosphatemia
Mineral-bone disorder in chronic kidney disease (CKD-MBD) is one of the most important factor determining prognosis in dialysis patients. CKD-MBD syndrome occurs at the CKD stage 2 and reaches its maximum in patients with end-stage renal disease ...
A. M. Essaian, A. R. Rind
doaj +1 more source
Abstract Background Periodontitis, a chronic inflammatory disease, is linked to systemic conditions such as cardiovascular and kidney disease. Serum α‐Klotho, an anti‐aging protein with anti‐inflammatory properties, has been associated with systemic diseases, but its role in periodontitis is unclear.
Hamoun Sabri +6 more
wiley +1 more source
Monogenic and syndromic obesity in children often arises from defects in the leptin–melanocortin pathway. Understanding these rare genetic causes not only clarifies mechanisms of appetite regulation but also enables precision therapies, offering hope beyond lifestyle interventions.
Hadel Khalil +2 more
wiley +1 more source

